Personalized brain stimulation gains FDA clearance for PTSD
Mental Health Weekly · 09.11.2026 · 36 (43) · 5-6
DOI: 10.1002/mhw.35070 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mental Health Weekly, online erschienen am 06.11.2026. Verfasst von Claudine McCarthy.
Abstract (Originalsprache)
Federal regulators have cleared a personalized treatment for post‐traumatic stress disorder (PTSD) that combines brain mapping with magnetic stimulation to guide care. Researchers say the approach could help expand options for individuals who do not respond adequately to existing therapies and may have implications for treating other mental health conditions.
Zitieren
APA
McCarthy, C. (2026). Personalized brain stimulation gains FDA clearance for PTSD. Mental Health Weekly, 36(43), 5-6. https://doi.org/10.1002/mhw.35070
Vancouver
McCarthy C. Personalized brain stimulation gains FDA clearance for PTSD. Mental Health Weekly. 2026;36(43):5-6. doi:10.1002/mhw.35070
BibTeX
@article{McCarthy2026,
author = {McCarthy, Claudine},
title = {Personalized brain stimulation gains FDA clearance for PTSD},
journal = {Mental Health Weekly},
year = {2026},
volume = {36},
number = {43},
pages = {5--6},
doi = {10.1002/mhw.35070}
}
EUVIMED